ConvaTec Group Plc
ConvaTec Group Plc (CNVVY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cnvvy · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
ConvaTec Group PlcYou CNVVY | $5.2B | N/A | — | — |
 DiaSorin S.p.A. DSRLF | $4.5B | 24.15x | +10.9% | $2.68 |
 Fielmann AG FLMNF | $4.4B | 21.13x | -3.0% | $2.43 |
 Fielmann AG FLMNY | $4.3B | 18.62x | -14.5% | $0.47 |
 Getinge AB (publ) GNGBY | $5.5B | 26.30x | +20.8% | $8.29 |
 Raia Drogasil S.A. RADLY | $6.2B | 32.99x | +51.5% | $0.77 |
 Shanghai Pharmaceuticals Holding Co., Ltd SHPMY | $5.6B | 7.47x | -65.7% | $7.70 |
Industry Average 6 peers with valid PE | — | 21.78x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for ConvaTec Group Plc (CNVVY) measures how much investors pay for each dollar of the company's trailing earnings. CNVVY's current PE ratio of N/A is calculated by dividing its stock price of $10.71 by its TTM earnings per share of —.
Frequently asked questions
CNVVY pe ratio · 6 questionsCNVVY's current PE ratio is N/A as of 2026-06-09, based on a stock price of $10.71 and TTM EPS of —. Data sourced from Financial Modeling Prep via CNVVY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ConvaTec Group Plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09